RUFFOLO ROBERT R
Insider CIK 1187308 · DFFN Director · ELTX Director · ARDS Director · LBRX Director · SGTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-08-31 | 2026-09-02 | 21,750 | — | $0 | 21,750 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2026-08-31 | 2026-09-02 | 21,750 | — | $0 | 21,750 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2026-06-03 | 2026-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 1,792 | — | $0 | 1,792 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | D To issuer deriv | 2025-09-10 | 2025-09-12 | 1,792 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 22,449 | — | $0 | 22,449 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 10,757 | — | $0 | 10,757 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | D To issuer deriv | 2025-09-10 | 2025-09-12 | 10,757 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | A Award deriv | 2025-09-10 | 2025-09-12 | 717 | — | $0 | 717 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | D To issuer deriv | 2025-09-10 | 2025-09-12 | 717 | — | $0 | 0 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2025-05-19 | 2025-05-20 | 7,900 | — | $0 | 7,900 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2024-11-21 | 2024-11-25 | 4,100 | — | $0 | 4,100 | SEC↗ |
| ELTX Elicio Therapeutics, Inc. | A Award deriv | 2023-12-28 | 2023-12-29 | 4,100 | — | $0 | 4,100 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 683 | $6.64 | $4.5K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 3,754 | $7.51 | $28.2K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | D To issuer deriv | 2023-08-11 | 2023-08-11 | 683 | $5.00 | $3.4K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2023-05-19 | 2023-05-22 | 8,888 | — | $0 | 8,888 | SEC↗ |
| ARDS Aridis Pharmaceuticals, In | A Award deriv | 2022-12-05 | 2022-12-07 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2022-05-26 | 2022-05-27 | 8,888 | — | $0 | 8,888 | SEC↗ |
| ARDS Aridis Pharmaceuticals, In | A Award deriv | 2021-10-04 | 2021-10-05 | 7,000 | — | $0 | 49,791 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | M Exercise deriv | 2021-07-01 | 2021-07-02 | 6,750 | — | $0 | 48,805 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | S Sale | 2021-07-01 | 2021-07-02 | 6,750 | $10.36 | $69.9K | 0 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | M Exercise | 2021-07-01 | 2021-07-02 | 6,750 | $0.57 | $3.8K | 6,750 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 8,888 | $9.97 | $88.6K | 8,888 | SEC↗ |
| SGTX Sigilon Therapeutics, Inc. | A Award deriv | 2020-12-03 | 2020-12-07 | 8,888 | — | $0 | 8,888 | SEC↗ |
| ARDS Aridis Pharmaceuticals, In | A Award deriv | 2019-08-13 | 2019-08-14 | 35,000 | — | $0 | 42,791 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2018-06-14 | 2018-06-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2018-01-02 | 2018-01-04 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DFFN Diffusion Pharmaceuticals | A Award deriv | 2017-06-29 | 2017-07-13 | 52,057 | — | $0 | 52,057 | SEC↗ |